Vedanta Biosciences: Funding, Investors & Team (Aug 2026)
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Vedanta Biosciences has raised $107M across 2 funding rounds on record, the most recent an undisclosed round announced in Feb 2024.
Vedanta Biosciences Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Vedanta Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Vedanta Biosciences raised $107M in a Series E announced in Apr 2023.
10 months later, an undisclosed round was announced in Feb 2024 with no disclosed amount.
Vedanta Biosciences Founders and Leadership Team
Contact details for the Vedanta Biosciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Vedanta Biosciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Vedanta Biosciences in Biotechnology and Cambridge
Companies Similar to Vedanta Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Vedanta Biosciences Funding FAQs
What does Vedanta Biosciences do?
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
How much funding has Vedanta Biosciences raised?
Vedanta Biosciences has raised $107M across 2 rounds on record.
When did Vedanta Biosciences last raise funding?
Vedanta Biosciences' most recent funding round on record was announced in Feb 2024. The amount was not disclosed.
Who founded Vedanta Biosciences?
FundedIQ lists Bernat Olle (Founder), Ruslan Medzhitov (Founder) at Vedanta Biosciences.
Where is Vedanta Biosciences headquartered?
Vedanta Biosciences is based in Cambridge, Massachusetts, United States.
How many employees does Vedanta Biosciences have?
Vedanta Biosciences is in the 101-250 employee band.
About FundedIQ's Vedanta Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vedanta Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.